---
figid: PMC4177547__2050-7771-1-30-1
figtitle: PI3K/Akt/mTOR pathway and relative inhibitors in NHL
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC4177547
filename: 2050-7771-1-30-1.jpg
figlink: /pmc/articles/PMC4177547/figure/F1/
number: F1
caption: The PI3K/Akt/mTOR pathway and relative inhibitors in NHL. Once RTKs binding
  to the growth factors, the PI3K signaling pathway is triggered. Activated PI3K could
  phosphorylate PI (4,5) P2 (PIP2) to produce PI(3,4,5)P3 (PIP3). This process is
  negatively regulated by PTEN. Akt inhibits the Rheb GTPase activity of TSC1/TSC2
  dimer by phosphorylating TSC2. Then activated Rheb stimulates mTOR to phosphorylate
  the p70S6 and 4E-binding protein (4EBP-1), resulting in dysregulation of protein
  synthesis and cell survival. On the other hand, mTORC2, another type of mTOR complex,
  could phosphorylate Akt and promote the complete activation of it.
papertitle: Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin
  lymphoma.
reftext: Xiaosheng Fang, et al. Biomark Res. 2013;1:30-30.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9436653
figid_alias: PMC4177547__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC4177547__F1
ndex: c87d215f-defc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4177547__2050-7771-1-30-1.html
  '@type': Dataset
  description: The PI3K/Akt/mTOR pathway and relative inhibitors in NHL. Once RTKs
    binding to the growth factors, the PI3K signaling pathway is triggered. Activated
    PI3K could phosphorylate PI (4,5) P2 (PIP2) to produce PI(3,4,5)P3 (PIP3). This
    process is negatively regulated by PTEN. Akt inhibits the Rheb GTPase activity
    of TSC1/TSC2 dimer by phosphorylating TSC2. Then activated Rheb stimulates mTOR
    to phosphorylate the p70S6 and 4E-binding protein (4EBP-1), resulting in dysregulation
    of protein synthesis and cell survival. On the other hand, mTORC2, another type
    of mTOR complex, could phosphorylate Akt and promote the complete activation of
    it.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - TSC1
  - CCL26
  - RICTOR
  - RHEB
  - RHEBP1
  - MTOR
  - MAPKAP1
  - MLST8
  - RPTOR
  - Pten
  - Akt1
  - Tsc2
  - Tsc1
  - Rictor
  - Rheb
  - Mtor
  - Rptor
---
